Retinopathy of Prematurity

Retinopathy of prematurity (ROP) is a disorder of the developing retinal blood vessels in infants born prematurely, in which incomplete normal vascularization is followed by abnormal, sometimes proliferative, vessel growth that can progress to retinal detachment and blindness. It is a leading cause of childhood visual impairment worldwide and is closely tied to the survival of very preterm, low-birth-weight infants.

Definition

Retinopathy of prematurity is a vasoproliferative retinal disorder of preterm infants in which the normally incomplete retinal vasculature at birth develops abnormally, classified by anatomical zone, severity stage, and the presence of plus disease, with severe forms threatening retinal detachment.

Scope

This entry covers the developmental basis of ROP, the two-phase mechanism of arrested then aberrant retinal vascularization, the international system for classifying it by zone, stage, and 'plus' disease, and the broad lines of evidence on detection and treatment. It is framed as a reference topic within pediatric and congenital eye disease and is not clinical guidance.

Key concepts

• Two-phase pathogenesis (vaso-obliteration then vasoproliferation)
• Retinal zones (I-III) and clock-hour extent
• Stages 1-5 of severity
• Plus disease
• Aggressive (posterior) ROP
• Oxygen exposure as a modifiable factor
• Screening of at-risk preterm infants

Mechanisms

ROP is generally described as a two-phase process. After premature birth, the relatively hyperoxic extrauterine environment and the loss of maternally supplied growth factors slow or halt normal retinal vascular growth, leaving peripheral retina avascular (phase 1). As the metabolically active but poorly perfused retina matures, it becomes hypoxic and drives a surge of angiogenic signaling, producing the abnormal, proliferative neovascularization of phase 2; severe proliferation and contraction can pull the retina off, causing detachment. The international classification captures severity through the posterior-to-anterior zone reached by vascularization, the morphological stage of the vascular response, and 'plus' disease (dilation and tortuosity of posterior vessels) as a marker of activity.

Clinical relevance

ROP is described here as a model of how disturbed retinal vascular development translates into a graded, classifiable disease whose severity guides whether intervention is considered. The entry explains the classification and evidence landscape for reference purposes and is not a basis for managing an individual infant; screening and treatment decisions belong to specialist care.

Epidemiology

ROP risk rises sharply with decreasing gestational age and birth weight, so its burden mirrors neonatal survival patterns. In high-resource settings it concentrates among the most extremely preterm infants, whereas in middle-income settings with expanding but uneven neonatal care, larger and more mature infants may also be affected, broadening the at-risk population and the screening challenge.

Evidence & guidelines

The International Classification of Retinopathy of Prematurity provides the shared vocabulary of zone, stage, and plus disease used worldwide. Treatment evidence has evolved from ablative laser therapy toward anti-VEGF approaches, with the BEAT-ROP trial demonstrating efficacy of intravitreal bevacizumab for stage 3+ disease, particularly in zone I; reference texts such as Taylor and Hoyt's synthesize the screening and management framework.

History

ROP was first described in the 1940s as retrolental fibroplasia and was soon linked to unmonitored supplemental oxygen in premature nurseries, prompting changes in oxygen practice. As neonatal intensive care improved survival of ever more preterm infants, the disease re-emerged with a more complex relationship to oxygen and growth factors, and the international classification (1984, revised 2005) standardized its description.

Debates

Anti-VEGF therapy versus laser ablation

Intravitreal anti-VEGF agents can spare peripheral retina and benefit posterior disease, but questions about optimal dosing, recurrence after treatment, the need for prolonged follow-up, and possible systemic effects in preterm infants keep the choice between modalities an active discussion.

Seminal works

• icrop-2005
• hellstrom-2013
• mintz-hittner-2011

Frequently asked questions

Why does prematurity cause retinopathy?

The retina is not fully vascularized until near term. Premature birth interrupts normal vessel growth; the immature retina later becomes hypoxic and drives abnormal new vessel formation, which in severe cases can lead to retinal detachment.

What do the 'zones,' 'stages,' and 'plus disease' mean?

They are the three axes of the international classification: zone describes how far normal vascularization has reached, stage describes the severity of the abnormal vascular response, and plus disease describes dilation and tortuosity of posterior vessels signaling active, more severe disease.